ロード中...
Use of Autologous Blood Components in Lymphedema Treatment: A Systematic Review
The main benefit of autologous therapies is its easier obtention and relatively lower concerns regarding ethical implications and patient safety. We conducted a systematic review of publications assessing the potential use of blood components (lymphocytes, red blood cells (RBCs), platelet-rich plasm...
保存先:
| 出版年: | Cureus |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Cureus
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6822891/ https://ncbi.nlm.nih.gov/pubmed/31700741 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.5638 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|